Closed · RFA-CE-22-011 · CFDA 93.136 · Discretionary

Understanding Polydrug Use Risk and Protective Factors, Patterns, and Trajectories to Prevent Drug Overdose

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

up to $350K
Award range
Closed
Status
February 24, 2022
Close date
5
Expected awards

The verdict

Understanding Polydrug Use Risk and Protective Factors, Patterns, and Trajectories to Prevent Drug Overdose is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Up to $350,000 across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

up to $350K
award range
Closed
application status
5
expected awards
93.136
CFDA program

Archived opportunity record

Understanding Polydrug Use Risk and Protectiv… is closed (last close February 24, 2022). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed February 24, 2022

Posted Dec 8 Closes Feb 24

Est. Total Funding

$5,250,000

Expected Awards

5

Instrument

Grant

Description

The Centers for Disease Control and Prevention (CDC) National Centers for Injury Prevention and Control (NCIPC) is soliciting investigator initiated research to improve our understanding of risk and protective factors, patterns, and trajectories related to polydrug use, with a focus on polydrug combinations most likely to result in nonfatal overdose or death, such as combinations including synthetic opioids. Polydrug combinations of interest include the following: Co-use of multiple opioids, knowingly or unknowingly (i.e., due to unknown adulterants) Co-use of non-opioid drugs (particularly psychostimulants [e.g., methamphetamine], cocaine, and benzodiazepines) AND opioids, knowingly or unknowingly Co-use of other combinations of drugs that may result in drug overdose Applicants should focus on identifying risk and protective factors, AND patterns, AND trajectories of polydrug use for either 1) the general population OR 2) one or more of the following subpopulations of interest: Persons who have experienced acute or chronic pain and used prescription opioids to manage their pain Persons who use cannabis, either medically or non-medically Applicants may also use prior research or preliminary data to justify an alternate subpopulation of interest, such as other groups which have been disproportionately affected by overdose. The overall goal of this research is to better understand risk and protective factors for and patterns and trajectories of polydrug use in order to inform targeted drug use and overdose prevention efforts.

Wide-open applicant board · 16 Grants.gov doors

Understanding Polydrug Use Risk and Protectiv… prints 16 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +12 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). 65 other Centers for Disease Control and Prevention - ERA listings share this eligibility-code string (10% of 640).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses
Code 25
Others (see official listing text)
Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Susan Neurath, PhD sfn8@cdc.gov

What to do next

Understanding Polydrug Use Risk and Protectiv… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.136 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants